Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arthritis
|
69 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
|
142 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
|
132 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
|
141 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Basal Cell Cancer
|
109 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Basal cell carcinoma
|
109 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Basal Cell Neoplasm
|
109 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Drug-Induced Liver Disease
|
29 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Pemphigus and fogo selvagem
|
3 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Latent Autoimmune Diabetes in Adults
|
12 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.710 | 1.000 | 2 | 2018 | 2019 | ||||
Dermatofibrosis lenticularis disseminata
|
3 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Hodgkin Disease
|
148 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Autoimmune Chronic Hepatitis
|
23 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Autoimmune hepatitis
|
22 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Congenital Thrombotic Thrombocytopenic Purpura
|
66 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Influenza
|
17 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1 | 2017 | 2017 | |||||
Purpura, Thrombotic Thrombocytopenic
|
13 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Ankylosing spondylitis
|
609 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.710 | 1.000 | 2 | 2016 | 2017 | ||||
Myositis
|
43 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 2 | 2016 | 2019 | ||||
White Blood Cell Count procedure
|
1322 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 2 | 2016 | 2019 | ||||
Blood basophil count (lab test)
|
452 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Cholangitis, Sclerosing
|
276 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Cystic Fibrosis
|
704 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Eosinophil count procedure
|
1144 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Granulocyte count
|
150 | 0.498 | 0.800 | 1 | 113834946 | missense variant | A/G | snv | 0.93 | 0.93 | 0.700 | 1.000 | 1 | 2016 | 2016 |